Status:
UNKNOWN
MED90 of Ropivacaine for Peripheral Nerve Block on Posture-evoked Pain in Spinal Anesthesia Positioning
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Hip Fractures
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
This study aims to determine the minimum effective dose of ropivacaine for peripheral nerve block on posture-evoked pain for spinal anesthesia in elderly patients with hip fracture. Three types of per...
Detailed Description
Patients with hip fractures are anticipated to endure sever pain caused by positional changes required for spinal anesthesia. Providing analgesia before positioning not only increases patient comfort ...
Eligibility Criteria
Inclusion
- Age 65 - 85 years
- American Society of Anesthesiologists physical statusⅠ- Ⅲ
- Patients will receive hip replacement
Exclusion
- Patient refusal
- Cognitive impairment(NRS pain score cannot be assessed)
- Peripheral neuropathy
- Mutiple furacture
- skin infection at the site of injection
- allergy to ropivacaine、lidocaine or bupivacaine
- contraindication to spinal anesthesia
Key Trial Info
Start Date :
January 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2024
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04705974
Start Date
January 25 2022
End Date
May 15 2024
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, Tongji Hospital
Wuhan, Hubei, China, 430060